NCT03418272

Brief Summary

This study is being done to determine if the bacteria found in your mouth (oral flora bacteria) in children admitted to the intensive care unit who need to be on a breathing machine is different from the oral flora in healthy children undergoing anesthesia for their dental caries. Children in the intensive care unit with a breathing tube are at a higher risk for getting a lung infection due to the bacteria in the mouth slipping into their lungs past the breathing tube over several days. This means that bacteria are found in the child's lung when this is normally not the case. If the bacteria in the mouth have changed from normal then they may get a pneumonia.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Feb 2023

Shorter than P25 for all trials

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 25, 2018

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 1, 2018

Completed
5 years until next milestone

Study Start

First participant enrolled

February 1, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2023

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2023

Completed
Last Updated

April 22, 2022

Status Verified

April 1, 2022

Enrollment Period

3 months

First QC Date

January 25, 2018

Last Update Submit

April 14, 2022

Conditions

Keywords

ICUORPneumoniaPICUPediatricPCR

Outcome Measures

Primary Outcomes (2)

  • Percentage of bacteria in sample

    PCR analysis

    By January 2019

  • Presence of bacteria in sample

    Culture analysis

    By January 2019

Study Arms (2)

Ventilated Pediatric Intensive Care Unit patient Group

This will be a prospective descriptive case series where tracheal cultures and PCR results will be analyzed at initial intubation and again several days into the ICU stay.

Diagnostic Test: Culture/PCR Analysis

Intubated OR patient Control Group

For the healthy operating room children, also a case series where a single set of studies will be obtained. tracheal cultures and PCR results will be analyzed after intubation These two groups will be compared, non-randomized.

Diagnostic Test: Culture/PCR Analysis

Interventions

Culture/PCR AnalysisDIAGNOSTIC_TEST

Microbes to be selectively cultured and PCR analysis to be conducted. Bacteria obtained in samples will be dispersed in non-selective Mueller Hinton Broth (Sigma-Aldrich), divided into two separate cultures and grown overnight at 37°C in aerobic condition and in 5% CO2 to assure survival of both aerobic and facultative anaerobic species. * Staphylococcus aureus (MSSA, MRSA) * Pseudomonas aeruginosa * Haemophilus influenza * Streptococcus pneumonia * Streptococcus Pyogenes Group B streptococci, * Klebsiella pneumonia * Moraxella catarrhalis

Intubated OR patient Control GroupVentilated Pediatric Intensive Care Unit patient Group

Eligibility Criteria

Age2 Years - 8 Years
Sexall
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

ICU Group: * Intubated within 12 hours * ASA 1 or 2 (ASA - AMERICAN SOCIETY ANESTEHESIOLOGY PREOPOERATIVE STATUS) * Age 2 to 8 OR Group: * ASA 1 or 2 * Elective dental surgery requiring intubation * Age 2 to 8

You may qualify if:

  • ICU Group:
  • Intubated within 12 hours
  • ASA 1 or 2 (ASA - AMERICAN SOCIETY ANESTEHESIOLOGY PREOPOERATIVE STATUS)
  • Age 2 to 8
  • OR Group:
  • ASA 1 or 2
  • Elective dental surgery requiring intubation
  • Age 2 to 8

You may not qualify if:

  • ICU Group:
  • Trauma patients
  • Postoperative patients
  • Children under 2 or over 8
  • OR Group:
  • Received antibiotics within the last week
  • Received prednisone within the last 2 weeks
  • Viral respiratory infective process within the last 2 weeks

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Pneumonia, Ventilator-AssociatedPneumonia, BacterialPneumonia

Condition Hierarchy (Ancestors)

Healthcare-Associated PneumoniaCross InfectionInfectionsRespiratory Tract InfectionsLung DiseasesRespiratory Tract DiseasesIatrogenic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsBacterial InfectionsBacterial Infections and Mycoses

Study Officials

  • Christopher Heard, MBChB, FRCA

    Jacobs School of Medicine

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor of Anesthesiology

Study Record Dates

First Submitted

January 25, 2018

First Posted

February 1, 2018

Study Start

February 1, 2023

Primary Completion

May 1, 2023

Study Completion

September 1, 2023

Last Updated

April 22, 2022

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will not share